scholarly article | Q13442814 |
P356 | DOI | 10.3109/21678421.2013.817587 |
P698 | PubMed publication ID | 23952600 |
P2093 | author name string | Andrew A Wolff | |
Jeremy M Shefner | |||
Lisa Meng | |||
P2860 | cites work | Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases | Q28260224 |
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis | Q58250570 | ||
P433 | issue | 7-8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
serum concentration | Q126107668 | ||
P304 | page(s) | 582-5 | |
P577 | publication date | 2013-12-01 | |
P1433 | published in | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | Q23928840 |
P1476 | title | The relationship between tirasemtiv serum concentration and functional outcomes in patients with ALS | |
P478 | volume | 14 |
Q46595019 | A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis |
Q34554820 | ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? |
Q38847200 | Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. |
Q33588537 | Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective |
Q38219475 | Assessment of disease progression and functional benefit in neurodegenerative disease: can we tell the difference? |
Q47815494 | Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment |
Q92813735 | Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment |
Q37701056 | Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases |
Q38947721 | Strength Testing in Motor Neuron Diseases |
Q28260629 | Targeting the sarcomere to correct muscle function |
Search more.